- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 02.02. | Flerie AB: Flerie's portfolio company Nanologica acquires Syntagon | 360 | GlobeNewswire (Europe) | Flerie AB (publ)'s portfolio company Nanologica has acquired Ardena Södertälje AB ('Syntagon'), a contract manufacturer with 45 employees. The acquisition strengthens Nanologica's production capacity... ► Artikel lesen | |
| 30.01. | Ardena Completes Divestment of Sweden Drug Substance Site to Nanologica | 2 | Contract Pharma | ||
| 30.01. | Nanologica AB: Nanologica Carries Out Directed Share Issues Of Approx. Sek 13.7 Million In Total, And A Fully Secured Rights Issue Of Approx. Sek 82.5 Million | 850 | GlobeNewswire (Europe) | NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA... ► Artikel lesen | |
| 29.01. | Ardena Holding NV.: Ardena completes divestment of its Södertälje drug substance site in Sweden to Nanologica | 549 | GlobeNewswire (Europe) | Ghent, Belgium, 29th January 2026 - Ardena, a specialist CDMO and bioanalytical CRO enabling precision medicines and other complex therapies, today announced that it has completed the divestment of... ► Artikel lesen | |
| 23.10.25 | Nanologica AB: Interim Report Q3 2025 Nanologica AB (publ) | 584 | GlobeNewswire (Europe) | FINANCIAL SUMMARY Net sales for the third quarter amounted to SEK 2,843 thousand (611) and for the nine-month period to SEK 15,930 thousand (7,822)Operating loss for the quarter amounted to SEK -10... ► Artikel lesen | |
| 22.10.25 | Nanologica AB: Nanologica AB (publ) Receives Order of appx. SEK 1 Million In China | 376 | GlobeNewswire (Europe) | Nanologica has received an order for the company's silica-based purification media NLAB Saga® from a new distribution partner in China. The order relates to sampling NLAB Saga® to pharmaceutical manufacturers.
"This... ► Artikel lesen | |
| 01.10.25 | Nanologica AB: Nanologica AB (publ) Enters the Insulin Market in China | 321 | GlobeNewswire (Europe) | Nanologica has entered the insulin market in China with an order of approximately SEK 2 million for the company's silica-based purification media NLAB Saga®. The customer is an insulin manufacturer... ► Artikel lesen | |
| 16.07.25 | The observation status for Nanologica AB (publ) is removed | 872 | GlobeNewswire | On May 23, 2025, the shares in Nanologica AB (publ) were given observation status with reference to a public takeover offer from Flerie Invest AB to the shareholders in Nanologica AB (publ).
Today... ► Artikel lesen | |
| NANOLOGICA Aktie jetzt für 0€ handeln | |||||
| 16.07.25 | Flerie AB: Flerie AB's subsidiary Flerie Invest AB announces final outcome of the mandatory cash offer to the shareholders of Nanologica AB (publ) | 654 | GlobeNewswire (Europe) | THIS PRESS RELEASE MAY NOT, DIRECTLY OR INDIRECTLY, BE DISTRIBUTED OR PUBLISHED IN OR INTO ANY JURISDICTION (INCLUDING WITHOUT LIMITATION AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE... ► Artikel lesen | |
| 10.07.25 | Nanologica AB: Interim Report Q2 2025 Nanologica AB (publ) | 632 | GlobeNewswire (Europe) | FINANCIAL SUMMARY Net sales for the second quarter amounted to SEK 2,335 thousand (2,174) and for the first half of the year to SEK 13,087 thousand (7,211)Operating loss for the quarter amounted to... ► Artikel lesen | |
| 13.06.25 | Nanologica AB: Statement From The Board Of Directors Of Nanologica AB (publ) Regarding The Mandatory Bid From Flerie Invest Ab | 714 | GlobeNewswire (Europe) | The Board of Directors of Nanologica AB (publ) ("Nanologica" or the "Company") unanimously recommends the shareholders of Nanologica not to accept the mandatory cash offer made by Flerie Invest AB ("Flerie")... ► Artikel lesen | |
| 12.06.25 | Flerie AB: Flerie's portfolio company Nanologica has received its first U.S. order | 883 | GlobeNewswire (Europe) | Stockholm, Sweden, June 12, 2025. Flerie AB's (publ) portfolio company Nanologica has announced that the company has secured an order for its silica-based purification media, NLAB Saga®, from a new... ► Artikel lesen | |
| 23.05.25 | Nanologica AB (publ) ges observationsstatus / Nanologica AB (publ) receives observation status | 1.335 | GlobeNewswire | Idag, den 23 maj 2025, offentliggjorde Flerie Invest AB ett budpliktsbud till övriga aktieägare i Nanologica AB (publ).
Enligt regelverket för Nasdaq Stockholm kan en emittent ges observationsstatus... ► Artikel lesen | |
| 23.05.25 | Nanologica AB: Comment from the Board of Nanologica AB (publ) Regarding the Mandatory Bid from Flerie Invest AB | 1.028 | GlobeNewswire (Europe) | Nanologica AB's (publ) ("Nanologica") main owner Flerie Invest AB ("Flerie") has today, May 23, 2025, made a mandatory cash offer of SEK 1.00 per share to the shareholders of Nanologica (the "Offer").... ► Artikel lesen | |
| 23.05.25 | Flerie AB: Flerie Invest AB announces a mandatory cash offer to the shareholders of Nanologica AB (publ) | 1.038 | GlobeNewswire (Europe) | THIS PRESS RELEASE MAY NOT, DIRECTLY OR INDIRECTLY, BE DISTRIBUTED OR PUBLISHED IN OR INTO ANY JURISDICTION (INCLUDING WITHOUT LIMITATION AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE... ► Artikel lesen | |
| 22.05.25 | Nanologica AB: Bulletin from the AGM 2025 Nanologica AB (publ) | 1.033 | GlobeNewswire (Europe) | Nanologica AB (publ) today May 22, 2025 held its Annual General Meeting in Stockholm, at which the following resolutions were adopted.
Adoption of the income statement and balance sheet, disposition... ► Artikel lesen | |
| 26.04.25 | Nanologica AB: Nanologica AB Informs that Flerie Invest AB has Passed the Threshold for Mandatory Bid | 967 | GlobeNewswire (Europe) | Nanologica's main owner Flerie Invest AB ("Flerie") has acquired additional shares in Nanologica AB with the result that a mandatory bid obligation has arisen. Flerie's total holding in Nanologica after... ► Artikel lesen | |
| 16.04.25 | Nanologica AB: Interim Report Q1 2025 Nanologica AB (publ) | 953 | GlobeNewswire (Europe) | FINANCIAL SUMMARY Net sales for the first quarter amounted to SEK 10,751 thousand (5,037)The operating loss amounted to SEK 9,241 thousand (15,331)Loss after tax amounted to SEK 10,171 thousand (16... ► Artikel lesen | |
| 24.03.25 | Nanologica AB: Nanologica AB Extends Existing Loan from Flerie | 1.328 | GlobeNewswire (Europe) | Nanologica has extended the existing loan from Flerie Invest AB. The end date for the loan has been extended to July 2, 2027 from previous July 5, 2025.
The loan will be paid off in stages according... ► Artikel lesen |
19 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 23,200 | -1,90 % | Formycon-Aktie: Darum lieber Finger weg! | Formycon gilt als einer der profiliertesten deutschen Entwickler von Biosimilars. Das Geschäftsmodell ist klar: Nachahmerprodukte komplexer Biopharmazeutika sollen nach Patentablauf der Originale Marktanteile... ► Artikel lesen | |
| VEECO INSTRUMENTS | 24,800 | 0,00 % | Axcelis Technologies, Inc.: Axcelis Stockholders Approve Merger with Veeco | BEVERLY, Mass., Feb. 6, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS) ("Axcelis") today announced that its stockholders have voted to approve all... ► Artikel lesen | |
| GOMSPACE | 2,115 | +1,44 % | GomSpace Group AB: GomSpace Reports an all-time high Q4 and a full year of significant growth | GomSpace delivers all-time high revenue, threefold growth in EBITDA, and secures major contracts for 2026, supported by a strong year-end balance sheet and cash position, as well as a 12% backlog increase... ► Artikel lesen | |
| ONTO INNOVATION | 192,00 | 0,00 % | Exploring Onto Innovation's Earnings Expectations | ||
| ZENTEK | 0,480 | -4,95 % | Zentek Ltd.: Zentek Provides Strategic and Regulatory Update | GUELPH, ON / ACCESS Newswire / February 17, 2026 / Zentek Ltd.("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN) and (OTC:ZENYF), further to its letter to shareholders dated January 29, 2026, wishes... ► Artikel lesen | |
| NVE | 56,00 | 0,00 % | Dividendenbekanntmachungen (02.02.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACUITY INC US00508Y1029 0,2 USD 0,1687 EUR ALLY FINANCIAL INC US02005N1000 0,3 USD 0,2531 EUR AMERISERV FINANCIAL INC US03074A1025 0... ► Artikel lesen | |
| ACACIA RESEARCH | 3,480 | +5,45 % | ACACIA RESEARCH CORP - 8-K, Current Report | ||
| GAUZY | 0,580 | 0,00 % | Gauzy Ltd. Announces Receipt of Nasdaq Notice Regarding Board Composition Requirements | TEL AVIV, Israel, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Gauzy Ltd. (NASDAQ: GAUZ) ("Gauzy" or the "Company"), a global leader in vision and light control technologies, today announced that it has received... ► Artikel lesen | |
| DOTZ NANO | 0,019 | +2,78 % | DOTZ NANO LIMITED: Dotz Partners with Filtration Technology Leader - Hengst | ||
| SOLESENCE | 1,250 | -5,30 % | Solésence, Inc.: Solésence Reports Third Quarter 2025 Financial Results | Advances Strategic Transformation with Key Changes in Executive Leadership, Product Development and Operations ROMEOVILLE, Ill., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN)... ► Artikel lesen | |
| CANATU | 10,400 | 0,00 % | Canatu Oyj: Canatu and DENSO enter Joint Development Agreement to develop large-scale CNT chamber, supporting potential automotive applications such as full windshield heaters | Canatu Plc Press release 2 January 2026 at 09:00 am EET
Canatu and DENSO enter Joint Development Agreement to develop large-scale CNT chamber, supporting potential automotive applications such as full... ► Artikel lesen | |
| NANOVIRICIDES | 0,890 | +4,71 % | MPox Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides | SHELTON, CONNECTICUT / ACCESS Newswire / February 12, 2026 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the... ► Artikel lesen | |
| RIBER | 5,400 | -1,64 % | RIBER: 2025 performance driven by production systems and the rollout of ROSIE | 2025 performance driven by production systems and the rollout of ROSIE Revenues of €40.3 million in line with guidanceOrder book at December 31, 2025: €26.9 million (+24%) Bezons (France), February... ► Artikel lesen | |
| FENDX TECHNOLOGIES | 0,374 | -8,78 % | Fendx Technologies Inc (2): Fendx Technologies issues 32,800 shares for debt | ||
| OBDUCAT | 0,005 | -41,86 % | NGM MARKET NOTICE: #26-16 Information regarding the last day of trading in paid subscribed units and the first day of trading in warrants issued by Obducat AB |
NANOLOGICA AB gehört der Branche Nanotechnologie an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,035 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NANOLOGICA AB finden Sie auf Wallstreet Online.